NCT03033316View on ClinicalTrials.gov

A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Multiple Myeloma
Interventions
DRUG

Dexamethasone

Sponsors

Collaborators (1)

Accelovance
All Listed Sponsors
collaborator

University Hospital, Aachen

OTHER

collaborator

Accelovance

INDUSTRY

lead

Enceladus Pharmaceuticals BV

INDUSTRY

NCT03033316 - A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma | Biotech Hunter | Biotech Hunter